X Li, J Liang, L Qu, S Liu, A Qin, H Liu,
T Wang… - Chemico-Biological …, 2022 - Elsevier
Doxorubicin (DOX) is an effective antitumor drug; however, but its clinical application is
seriously limited by the cardiotoxicity induced by its use. Recent studies have found that …